Serum mannose-binding lectin is a strong biomarker of diabetic retinopathy in chinese patients with diabetes

Diabetes Care
Peiliang GengYinying Lu

Abstract

Inflammation and complement activation initiated by mannose-binding lectin (MBL) may be implicated in the pathogenesis of diabetic vascular complications. We investigated serum MBL levels in patients with diabetes with and without diabetic retinopathy (DR). Serum MBL levels were determined in 348 patients with diabetes and in 100 healthy control subjects. The prediction value of MBL was compared with diabetes duration, hs-CRP, and other known predictors. Multivariate analyses were performed using logistic regression models. MBL levels on admission were significantly increased in patients with diabetes with DR (P < 0.0001) and vision-threatening DR (VTDR; P < 0.0001). Multivariate logistic regression analysis adjusted for common indictors showed that serum MBL levels ≥3,385 μg/L were an independent predictor of DR (odds ratio [OR] 3.14, 95% CI 1.77-5.57) and VTDR (OR 7.83, 95% CI 3.35-18.31). The area under the receiver operating characteristic curve of MBL was 0.81 (95% CI 0.76-0.86) for DR and 0.84 (95% CI 0.74-0.93) for VTDR. The current study demonstrated that MBL appears to be an independent biomarker for DR in the Chinese population, suggesting a possible role of MBL in the pathogenesis of DR complications in diabetes.

References

Jun 1, 1997·Diabetic Medicine : a Journal of the British Diabetic Association·D K NagiW C Knowler
Mar 7, 1998·American Journal of Human Genetics·R A Ezekowitz
May 4, 2000·The American Journal of Pathology·C D CollardG L Stahl
May 11, 2000·Proceedings of the National Academy of Sciences of the United States of America·J AcostaJ Halperin
Mar 12, 2003·The Journal of Clinical Endocrinology and Metabolism·Troels Krarup HansenGreet Van den Berghe
May 27, 2003·Diabetes Care·Robyn J TappUNKNOWN AusDiab Study Group
Oct 15, 2003·The Journal of Clinical Endocrinology and Metabolism·Troels Krarup HansenPer Løgstrup Poulsen
Feb 24, 2006·American Journal of Ophthalmology·Tien Yin WongSteven Shea
Oct 13, 2006·Archives of Internal Medicine·Troels Krarup HansenAllan Flyvbjerg
Sep 27, 2007·Ophthalmic Epidemiology·Barbara Eden Kobrin Klein
Jul 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Damon P EisenEmma S McBryde
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association
Mar 26, 2010·The New England Journal of Medicine·Wenying YangUNKNOWN China National Diabetes and Metabolic Disorders Study Group
May 27, 2010·Diabetes/metabolism Research and Reviews·Juliette FortpiedEmile Van Schaftingen
Aug 12, 2010·JAMA : the Journal of the American Medical Association·Xinzhi ZhangRonald Klein
Apr 13, 2011·Investigative Ophthalmology & Visual Science·Mohamed DiraniEcosse L Lamoureux
Jun 4, 2011·Diabetologia·H P HammesUNKNOWN DPV-Wiss Study Group
Jun 18, 2011·Journal of Perinatology : Official Journal of the California Perinatal Association·H ÖzkanF Budak
Nov 15, 2011·The American Journal of Pathology·Vasile I PavlovGregory L Stahl
Feb 4, 2012·Diabetes Care·Joanne W Y YauUNKNOWN Meta-Analysis for Eye Disease (META-EYE) Study Group
May 16, 2012·Current Diabetes Reports·Jie Ding, Tien Yin Wong
Jun 13, 2012·Diabetologia·H C LookerUNKNOWN Scottish Diabetes Research Network Epidemiology Group

❮ Previous
Next ❯

Citations

Jan 13, 2016·Immunologic Research·Sonia I VlaicuHorea Rus
Jun 3, 2017·Vision Research·Heping Xu, Mei Chen
Feb 14, 2018·Upsala Journal of Medical Sciences·Camilla MohlinKjell Johansson
Mar 10, 2020·PLoS Genetics·Fernando Riveros-MckayInês Barroso
Sep 24, 2020·Investigative Ophthalmology & Visual Science·Nikhil MandavaJesse M Smith
Aug 11, 2019·Molecular Immunology·Ramzi A Ajjan, Verena Schroeder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.